Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Corcept Therapeutics Inc Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

  • $18.9 Billion
  • Q2 2025

A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 24,231 shares of CORT stock, worth $2.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,231
Previous 22,315 8.59%
Holding current value
$2.14 Million
Previous $2.55 Million 30.22%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$62.24 - $91.93 $119,251 - $176,137
1,916 Added 8.59%
24,231 $1.78 Million
Q1 2025

May 13, 2025
BUY
$49.85 - $114.22 $120,038 - $275,041
2,408 Added 12.1%
22,315 $2.55 Million
Q4 2024

Feb 11, 2025
BUY
$44.66 - $60.85 $1,295 - $1,764
29 Added 0.15%
19,907 $1 Million
Q3 2024

Nov 07, 2024
BUY
$29.51 - $46.26 $4,013 - $6,291
136 Added 0.69%
19,878 $919,000
Q2 2024

Aug 12, 2024
BUY
$22.21 - $34.48 $3,375 - $5,240
152 Added 0.78%
19,742 $641,000
Q1 2024

May 08, 2024
BUY
$21.1 - $27.46 $2,468 - $3,212
117 Added 0.6%
19,590 $493,000
Q4 2023

Feb 09, 2024
SELL
$24.82 - $32.88 $1.01 Million - $1.34 Million
-40,858 Reduced 67.72%
19,473 $632,000
Q3 2023

Nov 09, 2023
SELL
$21.97 - $33.8 $919,642 - $1.41 Million
-41,859 Reduced 40.96%
60,331 $1.64 Million
Q2 2023

Aug 09, 2023
BUY
$21.44 - $25.15 $15,994 - $18,761
746 Added 0.74%
102,190 $2.27 Million
Q1 2023

May 09, 2023
SELL
$19.2 - $24.47 $20,985 - $26,745
-1,093 Reduced 1.07%
101,444 $2.2 Million
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $312,935 - $469,952
15,686 Added 18.06%
102,537 $2.08 Million
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $7,928 - $9,347
-321 Reduced 0.37%
86,851 $2.23 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $86,286 - $125,968
4,979 Added 6.06%
87,172 $2.07 Million
Q1 2022

May 12, 2022
BUY
$16.53 - $25.21 $172,936 - $263,747
10,462 Added 14.59%
82,193 $1.85 Million
Q4 2021

Feb 11, 2022
SELL
$17.1 - $23.34 $126,146 - $172,179
-7,377 Reduced 9.33%
71,731 $1.42 Million
Q3 2021

Nov 10, 2021
SELL
$19.68 - $22.53 $28,457 - $32,578
-1,446 Reduced 1.8%
79,108 $1.56 Million
Q2 2021

Aug 12, 2021
SELL
$19.97 - $24.43 $17,373 - $21,254
-870 Reduced 1.07%
80,554 $1.77 Million
Q1 2021

May 12, 2021
BUY
$23.49 - $30.56 $10,077 - $13,110
429 Added 0.53%
81,424 $1.94 Million
Q4 2020

Feb 12, 2021
BUY
$16.78 - $27.3 $4,899 - $7,971
292 Added 0.36%
80,995 $2.12 Million
Q3 2020

Nov 12, 2020
BUY
$12.46 - $19.98 $358,648 - $575,104
28,784 Added 55.44%
80,703 $1.41 Million
Q2 2020

Aug 11, 2020
BUY
$11.0 - $18.26 $1,881 - $3,122
171 Added 0.33%
51,919 $873,000
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $170,646 - $236,981
16,879 Added 48.41%
51,748 $615,000
Q4 2019

Feb 11, 2020
BUY
$12.06 - $16.96 $1,977 - $2,781
164 Added 0.47%
34,869 $422,000
Q3 2019

Nov 14, 2019
SELL
$10.41 - $14.66 $11,378 - $16,023
-1,093 Reduced 3.05%
34,705 $491,000
Q2 2019

Aug 13, 2019
SELL
$9.78 - $12.76 $312 - $408
-32 Reduced 0.09%
35,798 $399,000
Q1 2019

May 07, 2019
SELL
$10.03 - $15.71 $2,026 - $3,173
-202 Reduced 0.56%
35,830 $421,000
Q4 2018

Feb 11, 2019
BUY
$11.29 - $17.19 $122,169 - $186,012
10,821 Added 42.92%
36,032 $481,000
Q3 2018

Nov 08, 2018
BUY
$12.27 - $15.65 $61,092 - $77,921
4,979 Added 24.61%
25,211 $353,000
Q2 2018

Aug 03, 2018
BUY
$15.3 - $19.69 $309,549 - $398,368
20,232 New
20,232 $318,000

Others Institutions Holding CORT

# of Institutions
467
Shares Held
82.8M
Call Options Held
489K
Put Options Held
1.02M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $9.44B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email